{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T00:15:11Z","timestamp":1791764111506,"version":"4.3.4"},"reference-count":29,"publisher":"BMJ","issue":"3","license":[{"start":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T00:00:00Z","timestamp":1744243200000},"content-version":"unspecified","delay-in-days":147,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","award":["CO-UK-412-6446 A01"],"award-info":[{"award-number":["CO-UK-412-6446 A01"]}],"id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Sex Transm Infect"],"accepted":{"date-parts":[[2024,10,1]]},"published-print":{"date-parts":[[2025,5]]},"abstract":"<jats:sec><jats:title>Objectives<\/jats:title><jats:p>Expanding delivery of oral pre-exposure prophylaxis (PrEP) to community pharmacies could improve access, aligning well with the UK government\u2019s goals to eliminate new HIV acquisitions by 2030. Using the Capability, Opportunity, Motivation, Behaviour (COM-B) model for behaviour change, the aim of this research was to explore the barriers and facilitators of community pharmacy PrEP delivery, for pharmacists and community members.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Community members at elevated risk of acquiring HIV and community pharmacists were recruited to participate in semi-structured interviews. Interviews were recorded, transcribed, and thematically analysed within the framework of the COM-B model.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>17 interviews with pharmacists (pharmacy owners n=7; employed pharmacists n=6; locums n=4) and 24 with community members (black African women n=6; other women n=2; young adults aged 18\u201325 years n=6; transgender people n=6; female sex workers n=4) were carried out. Capability barriers included suboptimal awareness and knowledge of PrEP, pharmacy facilities and pharmacist roles in delivering public health services. Opportunity barriers included a lack of staff capacity, privacy and pharmacy screening and monitoring facilities. Motivational barriers included a concern that increased access could increase sexually transmitted infections and involve a financial cost. Capability facilitators included awareness raising, HIV and PrEP training and education. Opportunity facilitators included PrEP appointments and the accessibility of pharmacies. Motivational facilitators included a preference for pharmacy delivery over other models (eg, sexual health, General Practitioner (GP)), and a belief that it would be discrete and less stigmatising.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Pharmacy PrEP delivery is acceptable but for it to be feasible, results point to the need for the development of a behaviour change intervention focusing on education, training and awareness raising, targeting pharmacists and community members to stimulate patient activation and de-stigmatise HIV. This intervention would need to be facilitated by system and environmental changes (eg, commissioning service).<\/jats:p><\/jats:sec>","DOI":"10.1136\/sextrans-2024-056308","type":"journal-article","created":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T18:20:27Z","timestamp":1731608427000},"page":"160-167","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":11,"title":["Qualitative exploration of the barriers and facilitators to community pharmacy PrEP delivery for UK pharmacists and underserved community members using the COM-B model of behaviour change"],"prefix":"10.1136","volume":"101","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3671-7866","authenticated-orcid":false,"given":"China","family":"Harrison","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Family","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Kesten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Denford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Sabin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Copping","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsey","family":"Harryman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Cochrane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Saunders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ross","family":"Hamilton-Shaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Horwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2024,11,14]]},"reference":[{"key":"2025041509500743000_101.3.160.1","unstructured":"Department of Health and Social Care . HIV. hiv drug prep to be available across england. 2020."},{"key":"2025041509500743000_101.3.160.2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1108524"},{"key":"2025041509500743000_101.3.160.3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1011205"},{"key":"2025041509500743000_101.3.160.4","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0140-6736(15)00056-2","article-title":"Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial","volume":"387","author":"McCormack","year":"2016","journal-title":"The Lancet"},{"key":"2025041509500743000_101.3.160.5","unstructured":"BASHH . BHIVA\/bashh guidelines on the use of hiv pre-exposure prophylaxis (prep). 2018."},{"key":"2025041509500743000_101.3.160.6","doi-asserted-by":"publisher","DOI":"10.1111\/hiv.13492"},{"key":"2025041509500743000_101.3.160.7","unstructured":"Trust NA . HIV int he UK statistics, 2022. Available: https:\/\/www.nat.org.uk\/about-hiv\/hiv-statistics"},{"key":"2025041509500743000_101.3.160.8","unstructured":"Scotland PH . HIV in scotland. 2023."},{"key":"2025041509500743000_101.3.160.9","doi-asserted-by":"publisher","DOI":"10.1136\/sextrans-2020-054732"},{"key":"2025041509500743000_101.3.160.10","unstructured":"Terrence Higgins Trust . Heterosexual HIV diagnoses overtake those in gay and bisexual men in Scotland 2023, Available: https:\/\/www.tht.org.uk\/news\/heterosexual-hiv-diagnoses-overtake-those-gay-and-bisexual-men-scotland#:~:text=Last%20year%20in%20Scotland%2C%2042,sex%20with%20men%20(GBMSM)"},{"key":"2025041509500743000_101.3.160.11","unstructured":"Shah A , Mackay N , Ratna N , et al . HIV testing, prep, new hiv diagnoses and care outcomes for people accessing hiv services: 2023 report. In: The annual official statistics data release (data to end of December 2022) UK Health Security Agency. 2023."},{"key":"2025041509500743000_101.3.160.12","unstructured":"Ortblad S . The fidelity of a pharmacy-based oral hiv pre-exposure prophylaxis delivery model in kenya. 2023."},{"key":"2025041509500743000_101.3.160.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.japh.2020.01.026"},{"key":"2025041509500743000_101.3.160.14","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-054121","article-title":"PrEP distribution in pharmacies: a systematic review","volume":"12","author":"Kennedy","year":"2022","journal-title":"BMJ Open"},{"key":"2025041509500743000_101.3.160.15","unstructured":"Care DoHaS . Roadmap for meeting the prep needs of those at significant risk of hiv. 2023."},{"key":"2025041509500743000_101.3.160.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.japh.2020.06.005"},{"key":"2025041509500743000_101.3.160.17","doi-asserted-by":"publisher","DOI":"10.1016\/j.sapharm.2020.05.033"},{"key":"2025041509500743000_101.3.160.18","doi-asserted-by":"publisher","DOI":"10.1136\/sextrans-2020-054488"},{"key":"2025041509500743000_101.3.160.19","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp1912293"},{"key":"2025041509500743000_101.3.160.20","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofz360.1143","article-title":"1280. A Pharmacist-led PrEP Program at the Epicenter of the HIV Epidemic in Atlanta; Our Experience","volume":"6","author":"Smith","year":"2019","journal-title":"Open Forum Infect Dis"},{"key":"2025041509500743000_101.3.160.21","doi-asserted-by":"crossref","DOI":"10.1002\/jia2.26232","article-title":"Facilitators and barriers to community pharmacy PrEP delivery: a scoping review","volume":"27","author":"Harrison","year":"2024","journal-title":"J Int AIDS Soc"},{"key":"2025041509500743000_101.3.160.22","doi-asserted-by":"publisher","DOI":"10.1186\/1748-5908-6-42"},{"key":"2025041509500743000_101.3.160.23","doi-asserted-by":"publisher","DOI":"10.1191\/1478088706qp063oa"},{"key":"2025041509500743000_101.3.160.24","doi-asserted-by":"publisher","DOI":"10.1017\/S1463423607000138"},{"key":"2025041509500743000_101.3.160.25","doi-asserted-by":"publisher","DOI":"10.1093\/eurpub\/ckaa073"},{"key":"2025041509500743000_101.3.160.26","unstructured":"Dohascm. 2024. Available: https:\/\/healthmedia.blog.gov.uk\/2024\/02\/01\/pharmacy-first-what-you-need-to-know"},{"key":"2025041509500743000_101.3.160.27","unstructured":"PNC PSNC . PSNC briefing 009\/23: summary of the results of psnc\u2019s 2023 pharmacy pressures survey. 2023."},{"key":"2025041509500743000_101.3.160.28","doi-asserted-by":"publisher","DOI":"10.1007\/s10461-019-02453-4"},{"key":"2025041509500743000_101.3.160.29","doi-asserted-by":"publisher","DOI":"10.1136\/jfprhc-2012-100507"}],"container-title":["Sexually Transmitted Infections"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/sextrans-2024-056308","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T16:50:54Z","timestamp":1744735854000},"score":1,"resource":{"primary":{"URL":"https:\/\/sti.bmj.com\/lookup\/doi\/10.1136\/sextrans-2024-056308"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,14]]},"references-count":29,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,4,15]]},"published-print":{"date-parts":[[2025,5]]}},"alternative-id":["10.1136\/sextrans-2024-056308"],"URL":"https:\/\/doi.org\/10.1136\/sextrans-2024-056308","relation":{},"ISSN":["1368-4973","1472-3263"],"issn-type":[{"value":"1368-4973","type":"print"},{"value":"1472-3263","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,14]]}}}